66302-648 : Tyvaso Dpi 48 ug/1 Oral Inhalant


NDC: 66302-648
Labeler: United Therapeutics Corporation
Product Type: Human Prescription Drug
Drug Name:  Tyvaso Dpi
Dosage Form: Oral Inhalant
Application #: NDA214324
Rev. Date: 


NDC Package Codes:

  • 66302-648-03: 4 BLISTER PACK IN 1 KIT (66302‑648‑03) > 7 BLISTER PACK IN 1 BLISTER PACK > 4 INHALANT IN 1 BLISTER PACK

Active Ingredients:

  • Treprostinil

Dosage Strength:

  • 48 ug/1

Pharmaceutical Classes:

  • Prostacycline Vasodilator [EPC]
  • Prostaglandins I [CS]
  • Vasodilation [PE]

Related Products:

Based on records with the same trade name.
  • 66302-600 Tyvaso DpiTyvaso Dpi Kit by United Therapeutics Corporation
  • 66302-610 Tyvaso DpiTyvaso Dpi Kit by United Therapeutics Corporation
  • 66302-616 Tyvaso Dpi 16 ug/1 Oral Inhalant by United Therapeutics Corporation
  • 66302-620 Tyvaso DpiTyvaso Dpi Kit by United Therapeutics Corporation
  • 66302-630 Tyvaso DpiTyvaso Dpi Kit by United Therapeutics Corporation
  • 66302-632 Tyvaso Dpi 32 ug/1 Oral Inhalant by United Therapeutics Corporation
  • 66302-640 Tyvaso DpiTyvaso Dpi Kit by United Therapeutics Corporation
  • 66302-650 Tyvaso DpiTyvaso Dpi Kit by United Therapeutics Corporation
  • 66302-664 Tyvaso Dpi 64 ug/1 Oral Inhalant by United Therapeutics Corporation
  • 66302-716 Tyvaso Dpi 16 ug/1 Oral Inhalant by United Therapeutics Corporation
  • 66302-720 Tyvaso DpiTyvaso Dpi Kit by United Therapeutics Corporation
  • 66302-732 Tyvaso Dpi 32 ug/1 Oral Inhalant by United Therapeutics Corporation
  • 66302-748 Tyvaso Dpi 48 ug/1 Oral Inhalant by United Therapeutics Corporation
  • 66302-764 Tyvaso Dpi 64 ug/1 Oral Inhalant by United Therapeutics Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 66302-648 QR Code

< Prev: 66302-640Next: 66302-650 >

Related Discussions:

Orenitram & Treprostinil Availability
Hello. I'm looking for Orenitram tablets and Treprostinil. Can you tell me about their availability please? It's...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.